Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000228412.2 ABT-263 (navitoclax) Lung squamous cell carcinoma 0.007592899 Resistant
ENSG00000228412.2 ABT-263 (navitoclax) Liver hepatocellular carcinoma 0.028416814 Sensitive